Showing results (81-90 of 156) with videos related to

Sort By:
Pageof 16
Stem Cells (Dayton, Ohio)|October 21, 2015
Mesenchymal Stromal Cells Disrupt mTOR-Signaling and Aerobic Glycolysis During T-Cell ActivationMartin Böttcher, Andreas D Hofmann, Heiko Bruns, et al.
Annals of Clinical and Translational Neurology|April 24, 2026
Anti-CD19 CAR T Cells in Autoimmune Encephalitis: Inflammation Controlled, Neurodegeneration Unchecked?Dimitrios Mougiakakos, Marwa Al-Dubai, Denise Walther, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 19, 2011
Multipotent mesenchymal stromal cells express FoxP3: a marker for the immunosuppressive capacity?Mikael Sundin, Pádraig D'arcy, C Christian Johansson, et al.
Neuron|May 2, 2024
Treatment of concomitant myasthenia gravis and Lambert-Eaton myasthenic syndrome with autologous CD19-targeted CAR T cellsJeremias Motte, Melissa Sgodzai, Christiane Schneider-Gold, et al.
Cell Communication and Signaling : CCS|March 21, 2024
Activating mutations in JAK2 and CALR differentially affect intracellular calcium flux in store operated calcium entryVikas Bhuria, Tobias Franz, Conny Baldauf, et al.
Journal of Cancer Research and Clinical Oncology|August 3, 2023
AML consolidation therapy: timing mattersAdrian-Manuel Reimann, Enrico Schalk, Felix Jost, et al.
Clinical Nutrition ESPEN|May 22, 2024
Low subcutaneous adipose tissue and myosteatosis are prognostic factors after allogeneic hematopoietic stem cell transplantationFelix Barajas Ordonez, Yannic Zeller, Denise Wolleschak, et al.
Frontiers in Microbiology|November 4, 2022
Pleiotropic effects of antibiotics on T cell metabolism and T cell-mediated immunityTobias Franz, Jonas Negele, Philipp Bruno, et al.
Leukemia|June 9, 2026
Organelle proteomics reveals novel metabolic vulnerabilities in FLT3-ITD cellsValeria Bica, Anna Francesca Pacilè, Martin Boettcher, et al.
Pageof 16